ClinicalThought

Share

Program Content

Activities

  • MDM2/p53 Signaling in BTC
    Targeting the MDM2/p53 Signaling Pathway in Biliary Tract Cancers: Rationale and Current Status
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 09, 2024

    Expires: August 08, 2025

Provided by

ProCE Banner

Supporters

Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc.